206 related articles for article (PubMed ID: 22610481)
1. TSSC3 overexpression reduces stemness and induces apoptosis of osteosarcoma tumor-initiating cells.
Huang Y; Dai H; Guo QN
Apoptosis; 2012 Aug; 17(8):749-61. PubMed ID: 22610481
[TBL] [Abstract][Full Text] [Related]
2. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
3. TSSC3 promotes autophagy via inactivating the Src-mediated PI3K/Akt/mTOR pathway to suppress tumorigenesis and metastasis in osteosarcoma, and predicts a favorable prognosis.
Zhao GS; Gao ZR; Zhang Q; Tang XF; Lv YF; Zhang ZS; Zhang Y; Tan QL; Peng DB; Jiang DM; Guo QN
J Exp Clin Cancer Res; 2018 Aug; 37(1):188. PubMed ID: 30092789
[TBL] [Abstract][Full Text] [Related]
4. Salinomycin inhibits osteosarcoma by targeting its tumor stem cells.
Tang QL; Zhao ZQ; Li JC; Liang Y; Yin JQ; Zou CY; Xie XB; Zeng YX; Shen JN; Kang T; Wang J
Cancer Lett; 2011 Dec; 311(1):113-21. PubMed ID: 21835542
[TBL] [Abstract][Full Text] [Related]
5. TSSC3 overexpression associates with growth inhibition, apoptosis induction and enhances chemotherapeutic effects in human osteosarcoma.
Dai H; Huang Y; Li Y; Meng G; Wang Y; Guo QN
Carcinogenesis; 2012 Jan; 33(1):30-40. PubMed ID: 22021909
[TBL] [Abstract][Full Text] [Related]
6. Let-7d miRNA Shows Both Antioncogenic and Oncogenic Functions in Osteosarcoma-Derived 3AB-OS Cancer Stem Cells.
Di Fiore R; Drago-Ferrante R; Pentimalli F; Di Marzo D; Forte IM; Carlisi D; De Blasio A; Tesoriere G; Giordano A; Vento R
J Cell Physiol; 2016 Aug; 231(8):1832-41. PubMed ID: 26679758
[TBL] [Abstract][Full Text] [Related]
7. Sphere-forming stem-like cell populations with drug resistance in human sarcoma cell lines.
Fujii H; Honoki K; Tsujiuchi T; Kido A; Yoshitani K; Takakura Y
Int J Oncol; 2009 May; 34(5):1381-6. PubMed ID: 19360350
[TBL] [Abstract][Full Text] [Related]
8. Reduced tumorigenicity and drug resistance through the downregulation of octamer-binding protein 4 and Nanog transcriptional factor expression in human breast stem cells.
Huang ZJ; You J; Luo WY; Chen BS; Feng QZ; Wu BL; Jiang L; Luo Q
Mol Med Rep; 2015 Mar; 11(3):1647-54. PubMed ID: 25405855
[TBL] [Abstract][Full Text] [Related]
9. Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer.
Cho Y; Lee HW; Kang HG; Kim HY; Kim SJ; Chun KH
Oncotarget; 2015 Apr; 6(11):8709-21. PubMed ID: 25909162
[TBL] [Abstract][Full Text] [Related]
10. Epigenetic regulation of the pro-apoptosis gene TSSC3 in human osteosarcoma cells.
Li Y; Huang Y; Lv Y; Meng G; Guo QN
Biomed Pharmacother; 2014 Feb; 68(1):45-50. PubMed ID: 24268429
[TBL] [Abstract][Full Text] [Related]
11. Different Effects of BORIS/CTCFL on Stemness Gene Expression, Sphere Formation and Cell Survival in Epithelial Cancer Stem Cells.
Alberti L; Losi L; Leyvraz S; Benhattar J
PLoS One; 2015; 10(7):e0132977. PubMed ID: 26185996
[TBL] [Abstract][Full Text] [Related]
12. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
[TBL] [Abstract][Full Text] [Related]
13. GSKJ4, an H3K27me3 demethylase inhibitor, effectively suppresses the breast cancer stem cells.
Yan N; Xu L; Wu X; Zhang L; Fei X; Cao Y; Zhang F
Exp Cell Res; 2017 Oct; 359(2):405-414. PubMed ID: 28823831
[TBL] [Abstract][Full Text] [Related]
14. The expression of TSSC3 and its prognostic value in patients with osteosarcoma.
Wang X; He H; Zhang K; Peng W
Biomed Pharmacother; 2016 Apr; 79():23-6. PubMed ID: 27044808
[TBL] [Abstract][Full Text] [Related]
15. Metformin inhibits the proliferation, metastasis, and cancer stem-like sphere formation in osteosarcoma MG63 cells in vitro.
Chen X; Hu C; Zhang W; Shen Y; Wang J; Hu F; Yu P
Tumour Biol; 2015 Dec; 36(12):9873-83. PubMed ID: 26164004
[TBL] [Abstract][Full Text] [Related]
16. TSSC3 represses self-renewal of osteosarcoma stem cells and Nanog expression by inhibiting the Src/Akt pathway.
Yan GN; Tang XF; Zhang XC; He T; Huang YS; Zhang X; Meng G; Guo DY; Lv YF; Guo QN
Oncotarget; 2017 Oct; 8(49):85628-85641. PubMed ID: 29156746
[TBL] [Abstract][Full Text] [Related]
17. Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells.
Chang CC; Hsu WH; Wang CC; Chou CH; Kuo MY; Lin BR; Chen ST; Tai SK; Kuo ML; Yang MH
Cancer Res; 2013 Jul; 73(13):4147-57. PubMed ID: 23687336
[TBL] [Abstract][Full Text] [Related]
18. Osteosarcoma Stem Cells Have Active Wnt/β-catenin and Overexpress SOX2 and KLF4.
Martins-Neves SR; Corver WE; Paiva-Oliveira DI; van den Akker BE; Briaire-de-Bruijn IH; Bovée JV; Gomes CM; Cleton-Jansen AM
J Cell Physiol; 2016 Apr; 231(4):876-86. PubMed ID: 26332365
[TBL] [Abstract][Full Text] [Related]
19. A convenient and effective strategy for the enrichment of tumor-initiating cell properties in prostate cancer cells.
Zhang Y; Huang Y; Jin Z; Li X; Li B; Xu P; Huang P; Liu C
Tumour Biol; 2016 Sep; 37(9):11973-11981. PubMed ID: 27113741
[TBL] [Abstract][Full Text] [Related]
20. Side population cells isolated from human osteosarcoma are enriched with tumor-initiating cells.
Yang M; Yan M; Zhang R; Li J; Luo Z
Cancer Sci; 2011 Oct; 102(10):1774-81. PubMed ID: 21740477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
